Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study
2005

Impact of Albumin on Survival in Critically Ill Patients

Sample size: 3147 publication Evidence: moderate

Author Information

Author(s): Vincent Jean-Louis, Sakr Yasser, Reinhart Konrad, Sprung Charles L, Gerlach Herwig, Ranieri V Marco

Primary Institution: Erasme Hospital, Free University of Brussels

Hypothesis

Is albumin administration in the acutely ill associated with increased mortality?

Conclusion

Albumin administration was associated with decreased survival in this population of acutely ill patients.

Supporting Evidence

  • Patients who received albumin had a higher ICU mortality rate (35% vs 16%).
  • In matched pairs, ICU mortality rates were higher in patients who received albumin (34.8% vs 20.9%).
  • The study included 3,147 patients across multiple European ICUs.

Takeaway

Giving albumin to very sick patients might make them less likely to survive. It's like giving a special drink to someone who is already very sick, and it doesn't help them get better.

Methodology

This was a multicenter, observational study following patients admitted to ICUs over a two-week period, comparing those who received albumin to those who did not.

Potential Biases

Potential confounding factors were not fully accounted for, and the observational nature of the study may introduce bias.

Limitations

The study did not record the indications for albumin administration or measure serum albumin levels.

Participant Demographics

Patients included were older than 15 years, with a mix of surgical and medical admissions, and a higher prevalence of cancer and liver cirrhosis among those receiving albumin.

Statistical Information

P-Value

0.012

Confidence Interval

1.11–2.22

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/cc3895

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication